Fromkin Andrew J. 4
4 · Immunovant, Inc. · Filed Apr 3, 2025
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Fromkin Drew J
Director
Transactions
- Award
Common Stock
2025-04-01+16,188→ 108,101 total - Award
Stock Option (right to buy)
2025-04-01+7,600→ 7,600 totalExercise: $15.20Exp: 2035-04-01→ Common Stock (7,600 underlying)
Footnotes (2)
- [F1]These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
- [F2]The shares underlying the options will vest on April 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of such date.